Bexorg
PrivateLast Round
Grant
Oct 7, 2026
Total Funding Raised
$42.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Bexorg operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Series A round in October 2025.
Bexorg is a biotechnology company that has developed a whole-brain perfusion technology platform for central nervous system (CNS) drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bexorg Comparables
Compare Bexorg with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revalia Bio | 86% | |
| Vivodyne | 80% | |
| 28bio | 78% |
For institutional investors. Book with your work email.
Bexorg Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2026 | ||||
| Series A | Oct 15, 2025 | ||||
| Seed | Jun 11, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bexorg Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A |
| Engine Ventures | Series A |
| Starbloom Capital | Series A, Seed |
| E1 Ventures | Series A |
| Engine Ventures | Series A |
| Amplify Partners | Series A, Seed |
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
$28.3M grant awarded by ARPA-H
- Jul 25, 2026
Monthly visitors increased 54% MoM, from 4.9K to 7.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 7, 2026
Bexorg, Inc. receives up to $28.3M in ARPA-H funding in Connecticut on Oct 7th '26 to support a three-phase, 36-month project that aims to extend BrainEx perfusion from 24 hours to up to two weeks.
For institutional investors. Book with your work email.
Bexorg Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bexorg's valuation, stock price, and market status.
Is Bexorg a public or private company?
Bexorg is a private company.
What is the current stock price of Bexorg?
Bexorg is a private company, so its shares have no public market price. Caplight tracks Bexorg's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bexorg worth (valuation)?
Valuation information for Bexorg is not publicly available.
Can I buy Bexorg stock?
Bexorg shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bexorg's last funding round?
Bexorg's most recent funding round was Grant on October 7, 2026.
Who are the main investors in Bexorg?
Key investors in Bexorg include Engine Ventures, Engine Ventures.
Will Bexorg IPO soon?
No public IPO plans have been announced for Bexorg.
How can I track Bexorg secondary market activity?
Caplight tracks bids, offers, and trades in Bexorg's shares on secondary markets.